CP and myeloid sarcoma: The sex- and age-adjusted estimated median of SST and CP plasma protein levels was lower in MS cases, i.e., −0.37 HC SD (95% CI: −0.62, −0.12, uncorrected p < 0.004) and −0.38 HC SD (95% CI: −0.64, −0.13, uncorrected p < 0.004), respectively.